FDC
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination (NCT06733675) | Basilea Pharmaceutica | 2025-01-07 |
| To Compare the Pharmacokinetic Characteristics of the Fixed-dose Combination Compared to the Loose Combination (NCT05737771) | Daewoong Pharmaceutical Co. LTD. | 2023-01-25 |
Track FDC automatically
Every clearance here is in the API, with alerts when new ones post.